IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95%
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

IRLAB Therapeutics AB
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

IRLAB Therapeutics AB
Net Income Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
MOB
I
FLERIE

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
IRLAB Therapeutics AB
STO:IRLAB A
Net Income
-kr180.8m
CAGR 3-Years
-25%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Net Income
-kr353.1m
CAGR 3-Years
14%
CAGR 5-Years
-60%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Net Income
kr236.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Net Income
kr224.7m
CAGR 3-Years
24%
CAGR 5-Years
45%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Net Income
-kr27.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Net Income
-kr204.8m
CAGR 3-Years
-43%
CAGR 5-Years
-23%
CAGR 10-Years
N/A

See Also

What is IRLAB Therapeutics AB's Net Income?
Net Income
-180.8m SEK

Based on the financial report for Dec 31, 2023, IRLAB Therapeutics AB's Net Income amounts to -180.8m SEK.

What is IRLAB Therapeutics AB's Net Income growth rate?
Net Income CAGR 5Y
-20%

Over the last year, the Net Income growth was -60%. The average annual Net Income growth rates for IRLAB Therapeutics AB have been -25% over the past three years , -20% over the past five years .

Back to Top